Citations (7)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Maurizio Benucci, Arianna Damiani, Mariangela Manfredi, Maria Infantino, Valentina Grossi & Francesca Li Gobbi. (2019) Abatacept: from a budget impact model to cost-effectiveness analysis – data from RCT and real life. ClinicoEconomics and Outcomes Research 11, pages 405-409.
Read now
Read now
Jéssica Barreto Ribeiro dos Santos, Augusto Afonso Guerra Junior, Michael Ruberson Ribeiro da Silva, Alessandra Maciel Almeida, Francisco de Assis Acurcio & Juliana Alvares-Teodoro. (2019) First line of biological drugs in rheumatoid arthritis: a medication persistence analysis. Expert Review of Clinical Pharmacology 12:4, pages 363-370.
Read now
Read now
Katsuhiko Takabayashi, Fumihiko Ando & Takahiro Suzuki. (2019) Comparing the effectiveness of biological disease-modifying antirheumatic drugs using real-world data. Modern Rheumatology 29:1, pages 87-97.
Read now
Read now
Walid Fakhouri, Pedro Lopez-Romero, Silvia Antonelli, Serena Losi, Veronica Rogai, Stefano Buda, Diego Sangiorgi, Valentina Perrone & Luca Degli Esposti. (2018) Treatment patterns, health care resource utilization and costs of rheumatoid arthritis patients in Italy: findings from a retrospective administrative database analysis. Open Access Rheumatology: Research and Reviews 10, pages 103-111.
Read now
Read now
Jörg Mahlich & Rosarin Sruamsiri. (2016) Persistence with biologic agents for the treatment of rheumatoid arthritis in Japan. Patient Preference and Adherence 10, pages 1509-1519.
Read now
Read now
Articles from other publishers (2)
Elizabeth Wehler, Natalie Boytsov, Claudia Nicolay, Oscar Herrera-Restrepo & Stacey Kowal. (2019) A Budget Impact and Cost Per Additional Responder Analysis for Baricitinib for the Treatment of Moderate-to-Severe Rheumatoid Arthritis in Patients with an Inadequate Response to Tumor Necrosis Factor Inhibitors in the USA. PharmacoEconomics 38:1, pages 39-56.
Crossref
Crossref
Luca Degli Esposti, Valentina Perrone, Stefania Saragoni, Valerio Blini, Stefano Buda, Rosella D’avella, Gina Gasperini, Fabio Lena, Francesca Fanelli, Luca Gazzi & Francesco Giorgino. (2019) Insulin Glargine U100 Utilization in Patients with Type 2 Diabetes in an Italian Real-World Setting: A Retrospective Study. Journal of Diabetes Research 2019, pages 1-10.
Crossref
Crossref